NDC 50102-120-00 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-00
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Estradiol and Levonorgestrel | ESTRADIOL AND LEVONORGESTREL | Zydus Pharmaceuticals USA Inc. | b143ebda-f5d7-4288-9a00-ba10a64f481f | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 5W7SIA7YZW |
| Estradiol and Levonorgestrel | ESTRADIOL AND LEVONORGESTREL | Zydus Lifesciences Limited | 3fb00f13-d8b3-4391-9548-6ee912b2b5aa | 2026-11-02 | 5W7SIA7YZW | |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Nice-Pak Products, LLC | 9089e23e-ca4a-454f-8dcc-ff5a29a5a335 | 2026-09-22 | Warnings, Adverse reactions | 1K09F3G675 |
| Julie Morning After Pill | LEVONORGESTREL | Julie Products Inc. | 51afe483-1834-0528-e063-6294a90ac75d | 2026-09-17 | Warnings | 5W7SIA7YZW |
| Annovera | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | Mayne Pharma | eb18194f-2021-41fa-8bdf-31e0c0eb646b | 2026-09-17 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| My After Plan | LEVONORGESTREL | OHM LABORATORIES INC | 5baed3c3-bd9c-8a6c-e063-6294a90a699b | 2026-09-17 | Warnings | 5W7SIA7YZW |
| Calamine | CALAMINE, ZINC OXIDE | Nice-Pak Products, LLC | c370ee1f-1887-44e8-8d47-8ffa3c270ff5 | 2026-09-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Etonogestrel and Ethinyl Estradiol Vaginal | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | AvKARE | 05e172aa-e18a-427b-e063-6294a90ae22f | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Etonogestrel and Ethinyl Estradiol Vaginal Ring | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING | Northstar Rx LLC | 1488f5ae-3b34-fcd7-6049-215929b1d324 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| EnilloRing | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | Xiromed, LLC | 85a126f6-d3e0-9e12-73f9-6176ba36f58b | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Calamine | CALAMINE, PRAMOXINE HCL | United Natural Foods, Inc. dba UNFI | 0bc1a9b4-1210-4d9a-bbd2-40e9225e86ea | 2026-09-04 | Warnings, Adverse reactions | 1K09F3G675 |
| LEVONORGESTREL | LEVONORGESTREL | YYBA CORP | 5a71b870-9a0a-7997-e063-6294a90a882c | 2026-09-01 | Warnings | 5W7SIA7YZW |
| Calamine | FERRIC OXIDE RED | Your Military Exchanges | af95a66c-f063-4019-80c6-6f7dc4fee4d8 | 2026-08-28 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.